Vascular and Metabolic Effects of Omega-3 Fatty Acids

Phase 4

Completed

• Conditions: Hypertriglyceridemia
• Interventions: Drug: omega; Drug: placebo

• Registration Number: NCT01660932
• Lead Sponsor: Gachon University Gil Medical Center

Brief Summary

The investigators hypothesize that omega does-dependently improves vascular and insulin resistance.

Detailed Description

Not available

Study Timeline

• Study Start: 2011-03
• Status Verified: 2012-08
• Primary Completion: 2012-08
• Study First Submitted: 2012-08-08
• Study First Submitted QC: 2012-08-08
• Study First Posted: 2012-08-09
• Study Completion: 2012-09
• Last Update Submitted: 2014-11-01
• Last Update Posted: 2014-11-04

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 176

Inclusion Criteria

• hypertriglyceridemia

Exclusion Criteria

• overt liver disease, chronic renal failure, hypothyroidism, myopathy, uncontrolled diabetes (HbA1c > 9%), severe hypertension, stroke, acute coronary events, coronary revascularization within the preceding 3 months, or alcohol abuse

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
omega 1	omega	omega 1 gm
omega 2	omega	omega 2 gm
placebo	placebo	placebo
omega 4	omega	omega 4 gm

Primary Outcome Measures

Name	Time	Method
flow-mediated dilation	8 weeks of treatment

Secondary Outcome Measures

Name	Time	Method
insulin resistance	8 weeks of treatment

Trial Locations

Locations (1)

Gil Medical Center; 🇰🇷 Incheon, Korea, Republic of